TreeWAS – Variant ID: rs9360921

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
M16.9 Coxarthrosis, unspecified	1.000	0.000	0.000
M16 Coxarthrosis [arthrosis of hip]	0.999	0.001	0.000
M16.1 Other primary coxarthrosis	0.991	0.009	0.000
M16.3 Other dysplastic coxarthrosis	0.956	0.044	0.000
M16.0 Primary coxarthrosis, bilateral	0.903	0.097	0.000
M16.7 Other secondary coxarthrosis	0.806	0.193	0.000
M16.2 Coxarthrosis resulting from dysplasia, bilateral	0.792	0.208	0.000
M16.6 Other secondary coxarthrosis, bilateral	0.716	0.284	0.000
M16.4 Posttraumatic coxarthrosis, bilateral	0.716	0.284	0.000
M16.5 Other posttraumatic coxarthrosis	0.647	0.353	0.000
M15-M19 Arthrosis	0.121	0.879	0.000
M15 Polyarthrosis	0.097	0.903	0.000
M18 Arthrosis of first carpometacarpal joint	0.080	0.920	0.000
M15.2 Bouchard's nodes (with arthropathy)	0.079	0.921	0.000
M15.8 Other polyarthrosis	0.076	0.924	0.000
M15.9 Polyarthrosis, unspecified	0.069	0.930	0.000
M15.0 Primary generalised (osteo)arthrosis	0.069	0.930	0.000
M15.4 Erosive (osteo)arthrosis	0.069	0.930	0.000
M15.3 Secondary multiple arthrosis	0.069	0.930	0.000
M18.1 Other primary arthrosis of first carpometacarpal joint	0.064	0.936	0.000
M15.1 Heberden's nodes (with arthropathy)	0.062	0.938	0.000
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.059	0.941	0.000
C77.3 Axillary and upper limb lymph nodes	0.000	0.942	0.058
M18.5 Other secondary arthrosis of first carpometacarpal joint	0.057	0.943	0.000
M18.4 Other secondary arthrosis of first carpometacarpal joints, bilateral	0.057	0.943	0.000
M18.3 Other posttraumatic arthrosis of first carpometacarpal joint	0.057	0.943	0.000
M18.2 Posttraumatic arthrosis of first carpometacarpal joints, bilateral	0.057	0.943	0.000
C77.1 Intrathoracic lymph nodes	0.000	0.944	0.056
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.000	0.946	0.054
M15.00 Primary generalized (osteo)arthrosis, Multiple sites	0.050	0.950	0.000
M15.99 Polyosteoarthritis, unspecified	0.050	0.950	0.000
C77.8 Lymph nodes of multiple regions	0.000	0.950	0.050
M19 Other arthrosis	0.043	0.957	0.000
C77.0 Lymph nodes of head, face and neck	0.000	0.958	0.042
C77.5 Intrapelvic lymph nodes	0.000	0.961	0.039
M18.0 Primary arthrosis of first carpometacarpal joints, bilateral	0.033	0.967	0.000
M19.8 Other specified arthrosis	0.031	0.969	0.000
M19.1 Posttraumatic arthrosis of other joints	0.031	0.969	0.000
M17 Gonarthrosis [arthrosis of knee]	0.031	0.969	0.000
M19.2 Other secondary arthrosis	0.029	0.971	0.000
C77.9 Lymph node, unspecified	0.000	0.972	0.028
C77.2 Intra-abdominal lymph nodes	0.000	0.972	0.028
M17.0 Primary gonarthrosis, bilateral	0.027	0.973	0.000
C77.4 Inguinal and lower limb lymph nodes	0.000	0.974	0.026
M19.12 Post-traumatic arthrosis of other joints (Upper arm)	0.025	0.975	0.000
M19.14 Post-traumatic arthrosis of other joints (Hand)	0.025	0.975	0.000
H53.0 Amblyopia ex anopsia	0.000	0.976	0.024
M19.89 Other specified arthrosis (Site unspecified)	0.022	0.977	0.000
M19.88 Other specified arthrosis (Other)	0.022	0.977	0.000
M19.87 Other specified arthrosis (Ankle and foot)	0.022	0.977	0.000
M19.86 Other specified arthrosis (Lower leg)	0.022	0.977	0.000
M19.85 Other specified arthrosis (Pelvic region and thigh)	0.022	0.977	0.000
M19.84 Other specified arthrosis (Hand)	0.022	0.977	0.000
M19.83 Other specified arthrosis (Forearm)	0.022	0.977	0.000
M19.82 Other specified arthrosis (Upper arm)	0.022	0.977	0.000
M19.81 Other specified arthrosis (Shoulder region)	0.022	0.977	0.000
M19.80 Other specified arthrosis (Multiple sites)	0.022	0.977	0.000
M19.19 Post-traumatic arthrosis of other joints (Site unspecified)	0.022	0.978	0.000
M19.18 Post-traumatic arthrosis of other joints (Other)	0.022	0.978	0.000
M19.16 Post-traumatic arthrosis of other joints-Lower leg	0.022	0.978	0.000
M19.15 Post-traumatic arthrosis of other joints (Pelvic region and thigh)	0.022	0.978	0.000
M19.13 Post-traumatic arthrosis of other joints (Forearm)	0.022	0.978	0.000
M19.10 Post-traumatic arthrosis of other joints (Multiple sites)	0.022	0.978	0.000
M17.4 Other secondary gonarthrosis, bilateral	0.022	0.978	0.000
M17.2 Posttraumatic gonarthrosis, bilateral	0.022	0.978	0.000
M17.5 Other secondary gonarthrosis	0.022	0.978	0.000
M19.29 Other secondary arthrosis (Site unspecified)	0.021	0.979	0.000
M19.28 Other secondary arthrosis (Other)	0.021	0.979	0.000
M19.26 Other secondary arthrosis of other joints-Lower leg	0.021	0.979	0.000
M19.25 Other secondary arthrosis (Pelvic region and thigh)	0.021	0.979	0.000
M19.24 Other secondary arthrosis (Hand)	0.021	0.979	0.000
M19.23 Other secondary arthrosis (Forearm)	0.021	0.979	0.000
M19.22 Other secondary arthrosis (Upper arm)	0.021	0.979	0.000
M19.21 Other secondary arthrosis (Shoulder region)	0.021	0.979	0.000
M19.20 Other secondary arthrosis (Multiple sites)	0.021	0.979	0.000
M19.11 Post-traumatic arthrosis of other joints (Shoulder region)	0.021	0.979	0.000
M19.99 Arthrosis, unspecified (Site unspecified)	0.020	0.980	0.000
M19.9 Arthrosis, unspecified	0.020	0.980	0.000
M19.0 Primary arthrosis of other joints	0.019	0.981	0.000
M17.3 Other posttraumatic gonarthrosis	0.019	0.981	0.000
M19.27 Other secondary arthrosis (Ankle and foot)	0.018	0.981	0.000
M19.92 Arthrosis, unspecified (Upper arm)	0.017	0.983	0.000
M19.96 Arthrosis, unspecified-Lower leg	0.016	0.984	0.000
M19.09 Primary arthrosis of other joints (Site unspecified)	0.016	0.984	0.000
M19.03 Primary arthrosis of other joints (Forearm)	0.015	0.985	0.000
M19.91 Arthrosis, unspecified (Shoulder region)	0.015	0.985	0.000
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)	0.014	0.985	0.000
M19.08 Primary arthrosis of other joints (Other)	0.014	0.986	0.000
M19.06 Primary arthrosis of other joints-Lower leg	0.014	0.986	0.000
M19.05 Primary arthrosis of other joints (Pelvic region and thigh)	0.014	0.986	0.000
M19.07 Primary arthrosis of other joints (Ankle and foot)	0.014	0.986	0.000
M19.00 Primary arthrosis of other joints (Multiple sites)	0.013	0.987	0.000
M19.02 Primary arthrosis of other joints (Upper arm)	0.012	0.987	0.000
M19.98 Arthrosis, unspecified (Other)	0.012	0.988	0.000
H53.2 Diplopia	0.000	0.989	0.011
K35.9 Acute appendicitis, unspecified	0.000	0.990	0.010
M19.95 Arthrosis, unspecified (Pelvic region and thigh)	0.010	0.990	0.000
H53 Visual disturbances	0.000	0.990	0.010
M19.01 Primary arthrosis of other joints (Shoulder region)	0.010	0.990	0.000
M19.90 Arthrosis, unspecified (Multiple sites)	0.009	0.991	0.000
M19.04 Primary arthrosis of other joints (Hand)	0.009	0.991	0.000
M19.94 Arthrosis, unspecified (Hand)	0.008	0.992	0.000
E83.5 Disorders of calcium metabolism	0.008	0.992	0.000
R26.8 Other and unspecified abnormalities of gait and mobility	0.000	0.992	0.008
H53.6 Night blindness	0.000	0.992	0.008
H53.5 Colour vision deficiencies	0.000	0.992	0.008
H53.3 Other disorders of binocular vision	0.000	0.992	0.008
I67.8 Other specified cerebrovascular diseases	0.000	0.992	0.008
Z96.6 Presence of orthopaedic joint implants	0.008	0.992	0.000
B37.0 Candidal stomatitis	0.000	0.993	0.007
M19.93 Arthrosis, unspecified (Forearm)	0.006	0.993	0.000
K62.8 Other specified diseases of anus and rectum	0.007	0.993	0.000
I67 Other cerebrovascular diseases	0.000	0.993	0.007
L72.0 Epidermal cyst	0.000	0.994	0.006
I49.3 Ventricular premature depolarisation	0.000	0.994	0.006
I67.9 Cerebrovascular disease, unspecified	0.000	0.994	0.006
H53.1 Subjective visual disturbances	0.000	0.994	0.006
H53.9 Visual disturbance, unspecified	0.000	0.994	0.006
I67.1 Cerebral aneurysm, nonruptured	0.000	0.994	0.006
B37.8 Candidiasis of other sites	0.000	0.994	0.006
H53.8 Other visual disturbances	0.000	0.994	0.006
B37 Candidiasis	0.000	0.994	0.006
R26 Abnormalities of gait and mobility	0.000	0.995	0.005
E83 Disorders of mineral metabolism	0.005	0.995	0.000
I67.2 Cerebral atherosclerosis	0.000	0.995	0.005
M90.78 Fracture of bone in neoplastic disease (Other)	0.005	0.995	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.995	0.005
I67.7 Cerebral arteritis, not elsewhere classified	0.000	0.995	0.005
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.000	0.995	0.005
I67.5 Moyamoya disease	0.000	0.995	0.005
I67.4 Hypertensive encephalopathy	0.000	0.995	0.005
I67.3 Progressive vascular leukoencephalopathy	0.000	0.995	0.005
E83.3 Disorders of phosphorus metabolism	0.005	0.995	0.000
M90.72 Fracture of bone in neoplastic disease (Upper arm)	0.005	0.995	0.000
M90.7 Fracture of bone in neoplastic disease	0.005	0.995	0.000
B37.3 Candidiasis of vulva and vagina	0.000	0.995	0.005
E83.1 Disorders of iron metabolism	0.005	0.995	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.004	0.996	0.000
R26.2 Difficulty in walking, not elsewhere classified	0.000	0.996	0.004
I67.0 Dissection of cerebral arteries, nonruptured	0.000	0.996	0.004
B37.7 Candidal septicaemia	0.000	0.996	0.004
B37.6 Candidal endocarditis	0.000	0.996	0.004
B37.5 Candidal meningitis	0.000	0.996	0.004
B37.2 Candidiasis of skin and nail	0.000	0.996	0.004
R26.3 Immobility	0.000	0.996	0.004
B37.1 Pulmonary candidiasis	0.000	0.996	0.004
R26.1 Paralytic gait	0.000	0.996	0.004
B37.4 Candidiasis of other urogenital sites	0.000	0.996	0.004
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.996	0.004
E83.9 Disorder of mineral metabolism, unspecified	0.004	0.996	0.000
E83.8 Other disorders of mineral metabolism	0.004	0.996	0.000
E83.2 Disorders of zinc metabolism	0.004	0.996	0.000
E83.0 Disorders of copper metabolism	0.004	0.996	0.000
I61 Intracerebral haemorrhage	0.004	0.996	0.000
H53.4 Visual field defects	0.000	0.996	0.004
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems	0.000	0.996	0.004
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.004	0.996	0.000
N32.9 Bladder disorder, unspecified	0.000	0.996	0.004
M90.79 Fracture of bone in neoplastic disease (Site unspecified)	0.003	0.996	0.000
M90.77 Fracture of bone in neoplastic disease (Ankle and foot)	0.003	0.996	0.000
M90.76 Fracture of bone in neoplastic disease (Lower leg)	0.003	0.996	0.000
M90.74 Fracture of bone in neoplastic disease (Hand)	0.003	0.996	0.000
M90.73 Fracture of bone in neoplastic disease (Forearm)	0.003	0.996	0.000
M90.71 Fracture of bone in neoplastic disease (Shoulder region)	0.003	0.996	0.000
M90.70 Fracture of bone in neoplastic disease (Multiple sites)	0.003	0.996	0.000
M90 Osteopathies in diseases classified elsewhere	0.004	0.996	0.000
I61.5 Intracerebral haemorrhage, intraventricular	0.004	0.996	0.000
B37.9 Candidiasis, unspecified	0.000	0.996	0.004
I61.9 Intracerebral haemorrhage, unspecified	0.004	0.996	0.000
T43.2 Other and unspecified antidepressants	0.000	0.996	0.004
I61.8 Other intracerebral haemorrhage	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.997	0.003
R29 Other symptoms and signs involving the nervous and musculoskeletal systems	0.000	0.997	0.003
E83.4 Disorders of magnesium metabolism	0.003	0.997	0.000
T42.4 Benzodiazepines	0.000	0.997	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.003
M90.75 Fracture of bone in neoplastic disease (Pelvic region and thigh)	0.003	0.997	0.000
R26.0 Ataxic gait	0.000	0.997	0.003
R25-R29 Symptoms and signs involving the nervous and musculoskeletal systems	0.000	0.997	0.003
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.997	0.003
N92.3 Ovulation bleeding	0.000	0.997	0.003
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.997	0.003
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.997	0.003
T42.3 Barbiturates	0.000	0.997	0.003
T42.2 Succinimides and oxazolidinediones	0.000	0.997	0.003
T42.0 Hydantoin derivatives	0.000	0.997	0.003
I61.6 Intracerebral haemorrhage, multiple localised	0.003	0.997	0.000
H53-H54 Visual disturbances and blindness	0.000	0.997	0.003
M90.1 Periostitis in other infectious diseases classified elsewhere	0.003	0.997	0.000
N92.1 Excessive and frequent menstruation with irregular cycle	0.000	0.997	0.003
T42.1 Iminostilbenes	0.000	0.997	0.003
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.003	0.997	0.000
R27 Other lack of coordination	0.000	0.997	0.003
I61.4 Intracerebral haemorrhage in cerebellum	0.003	0.997	0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.003	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.997	0.003
M90.8 Osteopathy in other diseases classified elsewhere	0.003	0.997	0.000
M90.6 Osteitis deformans in neoplastic disease	0.003	0.997	0.000
M90.5 Osteonecrosis in other diseases classified elsewhere	0.003	0.997	0.000
M90.4 Osteonecrosis due to heamoglobinopathy	0.003	0.997	0.000
M90.3 Osteonecrosis in caisson disease	0.003	0.997	0.000
M90.2 Osteopathy in other infectious diseases classified elsewhere	0.003	0.997	0.000
M90.0 Tuberculosis of bone	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.997	0.003
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
T36 Poisoning by systemic antibiotics	0.000	0.997	0.003
K14.0 Glossitis	0.000	0.997	0.003
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.997	0.003
T40.4 Other synthetic narcotics	0.000	0.997	0.003
R29.4 Clicking hip	0.000	0.997	0.003
R29.3 Abnormal posture	0.000	0.997	0.003
R29.2 Abnormal reflex	0.000	0.997	0.003
R29.1 Meningismus	0.000	0.997	0.003
R29.0 Tetany	0.000	0.997	0.003
T40.6 Other and unspecified narcotics	0.000	0.997	0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
R27.8 Other and unspecified lack of coordination	0.000	0.997	0.003
T40.2 Other opioids	0.000	0.997	0.003
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.997	0.003
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.997	0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.997	0.003
M86-M90 Other osteopathies	0.003	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.997	0.002
T46.7 Peripheral vasodilators	0.000	0.997	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.997	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.997	0.002
M90.10 Periostitis in other infectious diseases classified elsewhere (Multiple sites)	0.002	0.997	0.000
T39.1 4-Aminophenol derivatives	0.000	0.997	0.003
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
R29.6 Tendency to fall, not elsewhere classified	0.000	0.997	0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.997	0.002
T40.8 Lysergide [LSD]	0.000	0.997	0.002
T40.7 Cannabis (derivatives)	0.000	0.997	0.002
T40.5 Cocaine	0.000	0.997	0.002
T40.3 Methadone	0.000	0.997	0.002
T40.1 Heroin	0.000	0.997	0.002
T40.0 Opium	0.000	0.997	0.002
T39.0 Salicylates	0.000	0.997	0.002
T46.1 Calcium-channel blockers	0.000	0.997	0.002
M89.55 Osteolysis (Pelvic region and thigh)	0.002	0.997	0.000
R27.0 Ataxia, unspecified	0.000	0.997	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.002
M90.19 Periostitis in other infectious diseases classified elsewhere (Site unspecified)	0.002	0.998	0.000
M90.18 Periostitis in other infectious diseases classified elsewhere (Other)	0.002	0.998	0.000
M90.17 Periostitis in other infectious diseases classified elsewhere (Ankle and foot)	0.002	0.998	0.000
M90.16 Periostitis in other infectious diseases classified elsewhere (Lower leg)	0.002	0.998	0.000
M90.15 Periostitis in other infectious diseases classified elsewhere (Pelvic region and thigh)	0.002	0.998	0.000
M90.14 Periostitis in other infectious diseases classified elsewhere (Hand)	0.002	0.998	0.000
M90.13 Periostitis in other infectious diseases classified elsewhere (Forearm)	0.002	0.998	0.000
M90.12 Periostitis in other infectious diseases classified elsewhere (Upper arm)	0.002	0.998	0.000
M90.11 Periostitis in other infectious diseases classified elsewhere (Shoulder region)	0.002	0.998	0.000
L40.5 Arthropathic psoriasis	0.000	0.998	0.002
R20.2 Paraesthesia of skin	0.000	0.998	0.002
S43.0 Dislocation of shoulder joint	0.002	0.998	0.000
T36.0 Penicillins	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
M86 Osteomyelitis	0.002	0.998	0.000
M89.5 Osteolysis	0.002	0.998	0.000
M89 Other disorders of bone	0.002	0.998	0.000
M90.09 Tuberculosis of bone (Site unspecified)	0.002	0.998	0.000
M90.08 Tuberculosis of bone (Other)	0.002	0.998	0.000
M90.07 Tuberculosis of bone (Ankle and foot)	0.002	0.998	0.000
M90.06 Tuberculosis of bone (Lower leg)	0.002	0.998	0.000
M90.05 Tuberculosis of bone (Pelvic region and thigh)	0.002	0.998	0.000
M90.04 Tuberculosis of bone (Hand)	0.002	0.998	0.000
M90.03 Tuberculosis of bone (Forearm)	0.002	0.998	0.000
M90.02 Tuberculosis of bone (Upper arm)	0.002	0.998	0.000
M90.01 Tuberculosis of bone (Shoulder region)	0.002	0.998	0.000
M90.00 Tuberculosis of bone (Multiple sites)	0.002	0.998	0.000
M90.29 Osteopathy in other infectious diseases classified elsewhere (Site unspecified)	0.002	0.998	0.000
M90.28 Osteopathy in other infectious diseases classified elsewhere (Other)	0.002	0.998	0.000
M90.27 Osteopathy in other infectious diseases classified elsewhere (Ankle and foot)	0.002	0.998	0.000
M90.26 Osteopathy in other infectious diseases classified elsewhere (Lower leg)	0.002	0.998	0.000
M90.25 Osteopathy in other infectious diseases classified elsewhere (Pelvic region and thigh)	0.002	0.998	0.000
M90.24 Osteopathy in other infectious diseases classified elsewhere (Hand)	0.002	0.998	0.000
M90.23 Osteopathy in other infectious diseases classified elsewhere (Forearm)	0.002	0.998	0.000
M90.22 Osteopathy in other infectious diseases classified elsewhere (Upper arm)	0.002	0.998	0.000
M90.21 Osteopathy in other infectious diseases classified elsewhere (Shoulder region)	0.002	0.998	0.000
M90.20 Osteopathy in other infectious diseases classified elsewhere (Multiple sites)	0.002	0.998	0.000
M90.39 Osteonecrosis in caisson disease (Site unspecified)	0.002	0.998	0.000
M90.38 Osteonecrosis in caisson disease (Other)	0.002	0.998	0.000
M90.37 Osteonecrosis in caisson disease (Ankle and foot)	0.002	0.998	0.000
M90.36 Osteonecrosis in caisson disease (Lower leg)	0.002	0.998	0.000
M90.35 Osteonecrosis in caisson disease (Pelvic region and thigh)	0.002	0.998	0.000
M90.34 Osteonecrosis in caisson disease (Hand)	0.002	0.998	0.000
M90.33 Osteonecrosis in caisson disease (Forearm)	0.002	0.998	0.000
M90.32 Osteonecrosis in caisson disease (Upper arm)	0.002	0.998	0.000
M90.31 Osteonecrosis in caisson disease (Shoulder region)	0.002	0.998	0.000
M90.30 Osteonecrosis in caisson disease (Multiple sites)	0.002	0.998	0.000
M90.49 Osteonecrosis due to haemoglobinopathy (Site unspecified)	0.002	0.998	0.000
M90.48 Osteonecrosis due to haemoglobinopathy (Other)	0.002	0.998	0.000
M90.47 Osteonecrosis due to haemoglobinopathy (Ankle and foot)	0.002	0.998	0.000
M90.46 Osteonecrosis due to haemoglobinopathy (Lower leg)	0.002	0.998	0.000
M90.45 Osteonecrosis due to haemoglobinopathy (Pelvic region and thigh)	0.002	0.998	0.000
M90.44 Osteonecrosis due to haemoglobinopathy (Hand)	0.002	0.998	0.000
M90.43 Osteonecrosis due to haemoglobinopathy (Forearm)	0.002	0.998	0.000
M90.42 Osteonecrosis due to haemoglobinopathy (Upper arm)	0.002	0.998	0.000
M90.41 Osteonecrosis due to haemoglobinopathy (Shoulder region)	0.002	0.998	0.000
M90.40 Osteonecrosis due to haemoglobinopathy (Multiple sites)	0.002	0.998	0.000
M90.59 Osteonecrosis in other diseases classified elsewhere (Site unspecified)	0.002	0.998	0.000
M90.58 Osteonecrosis in other diseases classified elsewhere (Other)	0.002	0.998	0.000
M90.57 Osteonecrosis in other diseases classified elsewhere (Ankle and foot)	0.002	0.998	0.000
M90.56 Osteonecrosis in other diseases classified elsewhere (Lower leg)	0.002	0.998	0.000
M90.55 Osteonecrosis in other diseases classified elsewhere (Pelvic region and thigh)	0.002	0.998	0.000
M90.54 Osteonecrosis in other diseases classified elsewhere (Hand)	0.002	0.998	0.000
M90.53 Osteonecrosis in other diseases classified elsewhere (Forearm)	0.002	0.998	0.000
M90.52 Osteonecrosis in other diseases classified elsewhere (Upper arm)	0.002	0.998	0.000
M90.51 Osteonecrosis in other diseases classified elsewhere (Shoulder region)	0.002	0.998	0.000
M90.50 Osteonecrosis in other diseases classified elsewhere (Multiple sites)	0.002	0.998	0.000
M90.69 Osteitis deformans in neoplastic disease (Site unspecified)	0.002	0.998	0.000
M90.68 Osteitis deformans in neoplastic disease (Other)	0.002	0.998	0.000
M90.67 Osteitis deformans in neoplastic disease (Ankle and foot)	0.002	0.998	0.000
M90.66 Osteitis deformans in neoplastic disease (Lower leg)	0.002	0.998	0.000
M90.65 Osteitis deformans in neoplastic disease (Pelvic region and thigh)	0.002	0.998	0.000
M90.64 Osteitis deformans in neoplastic disease (Hand)	0.002	0.998	0.000
M90.63 Osteitis deformans in neoplastic disease (Forearm)	0.002	0.998	0.000
M90.62 Osteitis deformans in neoplastic disease (Upper arm)	0.002	0.998	0.000
M90.61 Osteitis deformans in neoplastic disease (Shoulder region)	0.002	0.998	0.000
M90.60 Osteitis deformans in neoplastic disease (Multiple sites)	0.002	0.998	0.000
M90.89 Osteopathy in other diseases classified elsewhere (Site unspecified)	0.002	0.998	0.000
M90.88 Osteopathy in other diseases classified elsewhere (Other)	0.002	0.998	0.000
M90.87 Osteopathy in other diseases classified elsewhere (Ankle and foot)	0.002	0.998	0.000
M90.86 Osteopathy in other diseases classified elsewhere (Lower leg)	0.002	0.998	0.000
M90.85 Osteopathy in other diseases classified elsewhere (Pelvic region and thigh)	0.002	0.998	0.000
M90.84 Osteopathy in other diseases classified elsewhere (Hand)	0.002	0.998	0.000
M90.83 Osteopathy in other diseases classified elsewhere (Forearm)	0.002	0.998	0.000
M90.82 Osteopathy in other diseases classified elsewhere (Upper arm)	0.002	0.998	0.000
M90.81 Osteopathy in other diseases classified elsewhere (Shoulder region)	0.002	0.998	0.000
M90.80 Osteopathy in other diseases classified elsewhere (Multiple sites)	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
N92.4 Excessive bleeding in the premenopausal period	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002
T39.2 Pyrazolone derivatives	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
T50.5 Appetite depressants	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.002
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)	0.000	0.998	0.002
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.998	0.002
S82.10 Fracture of upper end of tibia (closed)	0.002	0.998	0.000
M89.0 Algoneurodystrophy	0.002	0.998	0.000
M86.9 Osteomyelitis, unspecified	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
M87 Osteonecrosis	0.002	0.998	0.000
N92 Excessive, frequent and irregular menstruation	0.000	0.998	0.002
S99.9 Unspecified injury of ankle and foot	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
B35-B49 Mycoses	0.000	0.998	0.002
K04.6 Periapical abscess with sinus	0.002	0.998	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.998	0.002
T78.3 Angioneurotic oedema	0.000	0.998	0.002
M86.8 Other osteomyelitis	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.4 Other laxatives	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.000	0.998	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
M89.03 Algoneurodystrophy (Forearm)	0.002	0.998	0.000
I34.1 Mitral (valve) prolapse	0.000	0.998	0.002
M86.5 Other chronic haematogenous osteomyelitis	0.002	0.998	0.000
M86.4 Chronic osteomyelitis with draining sinus	0.002	0.998	0.000
M86.3 Chronic multifocal osteomyelitis	0.002	0.998	0.000
M86.2 Subacute osteomyelitis	0.002	0.998	0.000
M86.1 Other acute osteomyelitis	0.002	0.998	0.000
M86.0 Acute haematogenous osteomyelitis	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.000	0.998	0.002
M86.98 Osteomyelitis, unspecified (Other)	0.002	0.998	0.000
M89.59 Osteolysis (Site unspecified)	0.002	0.998	0.000
M89.58 Osteolysis (Other)	0.002	0.998	0.000
M89.57 Osteolysis (Ankle and foot)	0.002	0.998	0.000
M89.56 Osteolysis (Lower leg)	0.002	0.998	0.000
M89.54 Osteolysis (Hand)	0.002	0.998	0.000
M89.53 Osteolysis (Forearm)	0.002	0.998	0.000
M89.52 Osteolysis (Upper arm)	0.002	0.998	0.000
M89.51 Osteolysis (Shoulder region)	0.002	0.998	0.000
M89.50 Osteolysis (Multiple sites)	0.002	0.998	0.000
T50.8 Diagnostic agents	0.000	0.998	0.002
M89.09 Algoneurodystrophy (Site unspecified)	0.002	0.998	0.000
M89.6 Osteopathy after poliomyelitis	0.002	0.998	0.000
M89.4 Other hypertrophic osteo-arthropathy	0.002	0.998	0.000
M89.2 Other disorders of bone development and growth	0.002	0.998	0.000
M89.1 Epiphyseal arrest	0.002	0.998	0.000
M86.6 Other chronic osteomyelitis	0.002	0.998	0.000
M88 Paget's disease of bone [osteitis deformans]	0.002	0.998	0.000
M87.9 Osteonecrosis, unspecified	0.002	0.998	0.000
M89.8 Other specified disorders of bone	0.002	0.998	0.000
O42.0 Premature rupture of membranes, onset of labour within 24 hours	0.000	0.998	0.002
M86.94 Osteomyelitis, unspecified (Hand)	0.002	0.998	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.002
M86.95 Osteomyelitis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
D68.8 Other specified coagulation defects	0.000	0.998	0.002
M89.3 Hypertrophy of bone	0.002	0.998	0.000
M87.8 Other osteonecrosis	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
M86.99 Osteomyelitis, unspecified (Site unspecified)	0.002	0.998	0.000
M86.96 Osteomyelitis, unspecified (Lower leg)	0.002	0.998	0.000
M86.93 Osteomyelitis, unspecified (Forearm)	0.002	0.998	0.000
M86.92 Osteomyelitis, unspecified (Upper arm)	0.002	0.998	0.000
M86.91 Osteomyelitis, unspecified (Shoulder region)	0.002	0.998	0.000
M86.90 Osteomyelitis, unspecified (Multiple sites)	0.002	0.998	0.000
M89.08 Algoneurodystrophy (Other)	0.002	0.998	0.000
M89.07 Algoneurodystrophy (Ankle and foot)	0.002	0.998	0.000
M89.06 Algoneurodystrophy (Lower leg)	0.002	0.998	0.000
M89.05 Algoneurodystrophy (Pelvic region and thigh)	0.002	0.998	0.000
M89.04 Algoneurodystrophy (Hand)	0.002	0.998	0.000
M89.02 Algoneurodystrophy (Upper arm)	0.002	0.998	0.000
M89.01 Algoneurodystrophy (Shoulder region)	0.002	0.998	0.000
M89.00 Algoneurodystrophy (Multiple sites)	0.002	0.998	0.000
N30.1 Interstitial cystitis (chronic)	0.000	0.998	0.002
N92.2 Excessive menstruation at puberty	0.000	0.998	0.002
B49 Unspecified mycosis	0.000	0.998	0.002
M87.3 Other secondary osteonecrosis	0.002	0.998	0.000
M87.1 Osteonecrosis due to drugs	0.002	0.998	0.000
M87.0 Idiopathic aseptic necrosis of bone	0.002	0.998	0.000
M86.87 Other osteomyelitis (Ankle and foot)	0.002	0.998	0.000
N32.0 Bladder-neck obstruction	0.000	0.998	0.002
B95.6 Staphylococcus aureus as the cause of diseases classified to other chapters	0.000	0.998	0.002
M89.81 Other specified disorders of bone (Shoulder region)	0.002	0.998	0.000
S02.00 Fracture of vault of skull (closed)	0.000	0.998	0.002
R30.9 Painful micturition, unspecified	0.000	0.998	0.002
B48 Other mycoses, not elsewhere classified	0.000	0.998	0.002
B47 Mycetoma	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations